AKTIENANLEIHE - TEVA PHARMACEUTICAL INDUSTRIES Stock

Certificat

DE000VU8EQM4

Delayed Deutsche Boerse AG 02:02:00 2024-05-22 pm EDT
101 EUR -0.09% Intraday chart for AKTIENANLEIHE - TEVA PHARMACEUTICAL INDUSTRIES
Current month-0.80%
1 month-1.10%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 101 -0.09%
24-05-21 101.1 -0.13%
24-05-20 101.2 0.00%
24-05-17 101.2 -0.02%
24-05-16 101.2 -0.12%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 02:02 pm EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Vontobel Vontobel
WKN VU8EQM
ISINDE000VU8EQM4
Date issued 2023-06-14
Strike 7.4 $
Maturity 2024-06-21 (30 Days)
Parity 0.01 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 107.2
Lowest since issue 99.28

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.88 USD
Average target price
17.34 USD
Spread / Average Target
+2.70%
Consensus